Tenpoint Therapeutics, Ltd., a global, commercial-stage ophthalmic pharmaceutical company focused on developing ...

Yuvezzi, an eye drop for the treatment of presbyopia, is now available in the U.S.

Major ophthalmic events in the first quarter of 2026 included treatments for presbyopia, age-related macular degeneration ...

Credit: Orasis Pharmaceuticals. The product is expected to be available in the first half of 2024. The Food and Drug Administration (FDA) has approved Qlosi ™ (pilocarpine hydrochloride ophthalmic ...

Successful explantation of a corneal microlens for presbyopia and implantation of a trifocal IOL in a patient who developed ...

Optometrist and Johnson & Johnson professional affairs consultant, Faye McDearmid, shares her four steps to successful patient communication about presbyopia ...

Presbyopia is an age-related medical condition whereby a person loses the ability to see objects at near distance clearly. Everyone will develop presbyopia at some point in their lives. Even if one ...

Presbyopia is a medical condition that presents with a loss of the ability to see objects in the near distance clearly. It is a gradual and progressive problem that typically manifests in the fifth ...

Dublin, Oct. 01, 2025 (GLOBE NEWSWIRE) -- The "Presbyopia Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" report has been added to ...

A new drug that could help more than 128 million Americans read without needing glasses has been submitted to the Food and Drug Administration for approval. The investigational eye drop – called ...

The US Food and Drug Administration has approved a landmark eye drop that uses a combined dose of medication to restore age-related near-sightedness, without the need for surgery, for a longer ...

This page lists all known medications that could potentially lead to 'Presbyopia' as a side effect. It's important to note that mild side effects are quite common with medications. The medication(s) ...